{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:03:34Z","timestamp":1788246214913,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014239","name":"North Carolina Central University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmcl.2021.128249","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:05:14Z","timestamp":1625529914000},"page":"128249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies"],"prefix":"10.1016","volume":"48","author":[{"given":"Shoaib","family":"Manzoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petreni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Kausar","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmcl.2021.128249_b0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2021.128249_b0010","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"issue":"7369","key":"10.1016\/j.bmcl.2021.128249_b0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature10464","article-title":"Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon","volume":"478","author":"Smeulders","year":"2011","journal-title":"Nature"},{"issue":"6138","key":"10.1016\/j.bmcl.2021.128249_b0020","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1233692","article-title":"Root Effect Hemoglobin May Have Evolved to Enhance General Tissue Oxygen Delivery","volume":"340","author":"Rummer","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2021.128249_b0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128249_b0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"26","key":"10.1016\/j.bmcl.2021.128249_b0035","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128249_b0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128249_b0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2019.1629419","article-title":"Carbonic anhydrases as disease markers","volume":"29","author":"Zamanova","year":"2019","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128249_b0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128249_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/13543776.2018.1519023","article-title":"Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2021.128249_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104778","article-title":"Quinoline-sulfamoyl carbamates\/sulfamide derivatives: Synthesis, cytotoxicity, carbonic anhydrase activity, and molecular modelling studies","volume":"110","author":"Cakmak","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0065","doi-asserted-by":"crossref","unstructured":"Pastorekova, S. Parkkila, S. Zavada, J. Tumor\u2010associated Carbonic Anhydrases and Their Clinical Significance, in: 2006: pp. 167\u2013216. 10.1016\/S0065-2423(06)42005-9.","DOI":"10.1016\/S0065-2423(06)42005-9"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128249_b0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14756360802218441","article-title":"Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines","volume":"24","author":"Morsy","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128249_b0075","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic Anhydrase as a Model for Biophysical and Physical-Organic Studies of Proteins and Protein\u2212Ligand Binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2021.128249_b0080","doi-asserted-by":"crossref","unstructured":"McKenna, R. Carbonic Anhydrase: Its Inhibitors and Activators. CRC Enzyme Inhibitors Series, Volume 1 Edited by Claudiu T. Supuran, Andrea Scozzafava (Universita degli Studi, Firenze), and Janet Conway (Pfizer Inc., New York). CRC Press LLC: Boca Raton, FL. 2004. xii, J Am Chem Soc 127; 2005, 3643\u20133643. 10.1021\/ja040999g.","DOI":"10.1021\/ja040999g"},{"key":"10.1016\/j.bmcl.2021.128249_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112897","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128249_b0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/14756366.2012.757223","article-title":"Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII","volume":"29","author":"Zubrien\u0117","year":"2014","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128249_b0095","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bmcl.2015.02.068","article-title":"Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense","volume":"25","author":"De Simone","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128249_b0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1107\/S1744309106020446","article-title":"X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes","volume":"62","author":"Fisher","year":"2006","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128249_b0105","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1107\/S0907444913007208","article-title":"X-ray structure of the first \u2018extremo-\u03b1-carbonic anhydrase\u2019, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1","volume":"69","author":"Di Fiore","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bmcl.2021.128249_b0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/anie.200461580","article-title":"In Situ Click Chemistry: Enzyme-Generated Inhibitors of Carbonic Anhydrase II","volume":"44","author":"Mocharla","year":"2005","journal-title":"Angew Chemie Int Ed"},{"issue":"19","key":"10.1016\/j.bmcl.2021.128249_b0115","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting Hypoxic Tumor Cell Viability with Carbohydrate-Based Carbonic Anhydrase IX and XII Inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0120","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic Anhydrase Inhibitors: Inhibition of Isozymes I, II, and IX with Triazole-Linked O -Glycosides of Benzene Sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128249_b0125","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/jm701426t","article-title":"Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides","volume":"51","author":"Wilkinson","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0130","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0135","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmcl.2021.128249_b0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejmech.2014.10.008","article-title":"In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications","volume":"97","author":"Pa\u0142asz","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0145","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.bmc.2005.12.060","article-title":"The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets","volume":"14","author":"Legraverend","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128249_b0150","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chem Rev"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128249_b0155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2021.128249_b0160","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1021\/jm0009540","article-title":"Synthesis and Antitumor Activities of Novel Pyrimidine Derivatives of 2,3- O, O -Dibenzyl-6-deoxy- l -ascorbic Acid and 4,5-Didehydro-5,6- dideoxy- l -ascorbic Acid","volume":"43","author":"Rai\u0107-Mali\u0107","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128249_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113224","article-title":"Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer\u2019s action: Design, synthesis, crystal structure and in-vitro biological evaluation","volume":"215","author":"Manzoor","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128249_b0170","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/jm9003126","article-title":"Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New \u03b2-Carbonic Anhydrase from Mycobacterium tuberculosis","volume":"52","author":"Nishimori","year":"2009","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128249_b0175","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21004765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21004765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:43:50Z","timestamp":1760773430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21004765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S0960894X21004765"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128249","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128249"}}